BiVictriX Therapeutics
Alderley Edge
About BiVictriX Therapeutics
BiVictriX is a drug discovery and development company. Their services include oncology, haematological malignancies, bispecific ADC therapeutics, biotherapeutics, immunotherapy, antibody research, and drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $473.3K
- Funding stage: IPO
- Last round: Grant (Jun 2024)
- Ticker: lse:BVX
- Website: bivictrix.com
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bivictrix-therapeutics-112878 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.